![Kevin Foley](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Kevin Foley is the founder of DuraStat LLC.
He held the title of Director at the company.
Actieve functies van Kevin Foley
Bedrijven | Functie | Begin |
---|---|---|
DuraStat LLC
![]() DuraStat LLC Medical SpecialtiesHealth Technology DuraStat LLC is a medical device company that specializes in precision suturing. DuraStat recently relocated to Austin, TX to centralize logistics and training efforts in a location accessible to all regions, while taking part in the rapidly expanding technology development community in the region. The company is based in Austin, TX and Adam Azzara has been the CEO of the company since 2019. The company's unique approach eliminates wrist rotation, enabling fast and atraumatic tissue approximation. The company was founded by Greg Anderson and Mark Kurd from Thomas Jefferson University and Rothman Institute, and developed for scalability with Kevin Foley from Semmes-Murphey and Alex Lukianov. | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
DuraStat LLC
![]() DuraStat LLC Medical SpecialtiesHealth Technology DuraStat LLC is a medical device company that specializes in precision suturing. DuraStat recently relocated to Austin, TX to centralize logistics and training efforts in a location accessible to all regions, while taking part in the rapidly expanding technology development community in the region. The company is based in Austin, TX and Adam Azzara has been the CEO of the company since 2019. The company's unique approach eliminates wrist rotation, enabling fast and atraumatic tissue approximation. The company was founded by Greg Anderson and Mark Kurd from Thomas Jefferson University and Rothman Institute, and developed for scalability with Kevin Foley from Semmes-Murphey and Alex Lukianov. | Health Technology |